Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transcatheter Arterial Chemoembolization”

128 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 128 results

Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Large-scale testing (Phase 3)UnknownNCT00501813
What this trial is testing

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 160
Large-scale testing (Phase 3)Ended earlyNCT01465464
What this trial is testing

Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Taiho Pharmaceutical Co., Ltd. 888
Not applicableUnknownNCT03285867
What this trial is testing

Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Failure
Nanfang Hospital, Southern Medical University 200
Not applicableStudy completedNCT00834028
What this trial is testing

Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Not applicableLooking for participantsNCT05072041
What this trial is testing

Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Next Biomedical Co., Ltd. 150
Not applicableStudy completedNCT02552745
What this trial is testing

Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Not applicableLooking for participantsNCT05984511
What this trial is testing

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor InvasionTumor Thrombus
Third Affiliated Hospital, Sun Yat-Sen University 234
Not applicableUnknownNCT01393197
What this trial is testing

Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)

Who this might be right for
Carcinoma, Hepatocellular
Tianjin Medical University Cancer Institute and Hospital 2,480
Testing effectiveness (Phase 2)UnknownNCT04157140
What this trial is testing

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Jinglong Chen 48
Not applicableStudy completedNCT04523350
What this trial is testing

Instylla HES Hypervascular Tumor Pivotal Study

Who this might be right for
Hypervascular Tumors
Instylla, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT04297280
What this trial is testing

TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Large-scale testing (Phase 3)UnknownNCT00843934
What this trial is testing

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Nihon University 450
Not applicableActive Not RecruitingNCT07065786
What this trial is testing

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

Who this might be right for
Transcatheter Arterial ChemoembolizationUnresectable Hepatocellular Carcinoma
Zhongda Hospital 550
Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Large-scale testing (Phase 3)Study completedNCT00467974
What this trial is testing

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 98
Testing effectiveness (Phase 2)Looking for participantsNCT04954781
What this trial is testing

TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Large-scale testing (Phase 3)UnknownNCT02987907
What this trial is testing

The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 220
Not applicableStudy completedNCT00539253
What this trial is testing

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Load More Results